Afzal Nikaein

843 total citations
35 papers, 693 citations indexed

About

Afzal Nikaein is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Afzal Nikaein has authored 35 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Transplantation and 8 papers in Surgery. Recurrent topics in Afzal Nikaein's work include Renal Transplantation Outcomes and Treatments (13 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (5 papers). Afzal Nikaein is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (5 papers). Afzal Nikaein collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Afzal Nikaein's co-authors include Marvin J. Stone, R N Jenkins, Peter E. Lipsky, Katheryn Meek, Adriana Fontes Zimmermann, Lars Bäckman, Robert M. Goldstein, Thomas A. Gonwa, Marlon F. Levy and P. B. Carroll and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Afzal Nikaein

32 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afzal Nikaein United States 13 290 263 245 113 92 35 693
Beth Colombe United States 12 188 0.6× 238 0.9× 197 0.8× 54 0.5× 58 0.6× 36 602
Simon C.D. Grant United Kingdom 8 212 0.7× 90 0.3× 159 0.6× 42 0.4× 86 0.9× 9 523
Beatrice Coupes United Kingdom 16 187 0.6× 79 0.3× 100 0.4× 22 0.2× 55 0.6× 27 713
Rens Kraaijeveld Netherlands 15 317 1.1× 370 1.4× 170 0.7× 19 0.2× 128 1.4× 27 650
B. H. Markus Germany 16 155 0.5× 321 1.2× 595 2.4× 310 2.7× 118 1.3× 45 918
D. Canioni France 12 142 0.5× 30 0.1× 115 0.5× 73 0.6× 92 1.0× 24 636
Natacha Patey‐Mariaud de Serre France 14 296 1.0× 74 0.3× 261 1.1× 11 0.1× 163 1.8× 21 828
Judy A. Falk Canada 10 226 0.8× 221 0.8× 153 0.6× 16 0.1× 54 0.6× 17 500
Marion E. Paape Netherlands 8 334 1.2× 112 0.4× 95 0.4× 11 0.1× 54 0.6× 9 554
Sultan Celik Germany 13 316 1.1× 39 0.1× 149 0.6× 14 0.1× 107 1.2× 16 647

Countries citing papers authored by Afzal Nikaein

Since Specialization
Citations

This map shows the geographic impact of Afzal Nikaein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afzal Nikaein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afzal Nikaein more than expected).

Fields of papers citing papers by Afzal Nikaein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afzal Nikaein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afzal Nikaein. The network helps show where Afzal Nikaein may publish in the future.

Co-authorship network of co-authors of Afzal Nikaein

This figure shows the co-authorship network connecting the top 25 collaborators of Afzal Nikaein. A scholar is included among the top collaborators of Afzal Nikaein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afzal Nikaein. Afzal Nikaein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nikaein, Afzal, et al.. (2018). Single center observation of the role of pre-existing HLA-DP antibodies in humoral rejection following renal transplantation. Transplant Immunology. 51. 58–61. 7 indexed citations
2.
Nikaein, Afzal, Nadim El‐Awar, Judson Hunt, et al.. (2011). Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices. The Journal of Heart and Lung Transplantation. 31(5). 443–447. 17 indexed citations
4.
Nikaein, Afzal, et al.. (2008). CD30, a marker to detect the high‐risk kidney transplant recipients. Clinical Transplantation. 22(6). 765–769. 23 indexed citations
5.
Nikaein, Afzal, et al.. (2007). Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation. Clinical Transplantation. 21(6). 744–747. 17 indexed citations
6.
Hunt, Judson, Michael J. Mack, Alyce Anderson, et al.. (2006). Evaluation of Soluble CD30 as an Immunologic Marker in Heart Transplant Recipients. Transplantation Proceedings. 38(10). 3689–3691. 12 indexed citations
7.
Henry, C. H., Afzal Nikaein, & Larry M. Wolford. (2002). Analysis of human leukocyte antigens in patients with internal derangement of the temporomandibular joint. Journal of Oral and Maxillofacial Surgery. 60(7). 778–783. 12 indexed citations
8.
El‐Awar, Nadim, et al.. (2002). MOST PATIENTS WHO REJECT A KIDNEY TRANSPLANT HAVE ANTI‐HLA‐ANTIBODIES. Tissue Antigens. 60(6). 553–553. 4 indexed citations
9.
Lemster, Bonnie, P. B. Carroll, Horacio Rilo, et al.. (1995). IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clinical & Experimental Immunology. 99(2). 148–154. 88 indexed citations
10.
Nikaein, Afzal, et al.. (1995). Comparison of monoclonal antibodies for flow cytometric analysis of HLA‐B27 antigen. Cytometry. 22(1). 65–69. 13 indexed citations
11.
Mulligan, David C., et al.. (1995). Monitoring of allograft recipients for the development of HLA‐specific antibodies: Elimination of OKT3 as a complicating factor. Clinical Transplantation. 9(6). 438–441. 2 indexed citations
12.
Nikaein, Afzal, Lars Bäckman, Linda W. Jennings, et al.. (1994). HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching. Human Immunology. 40. 6–6. 4 indexed citations
13.
Collins, Robert H., John Anastasi, Leon W.M.M. Terstappen, et al.. (1993). Donor-Derived Long-Term Multilineage Hematopoiesis in a Liver-Transplant Recipient. New England Journal of Medicine. 328(11). 762–765. 79 indexed citations
14.
Nikaein, Afzal, et al.. (1993). The effect of diet changes on the immune system of breast cancer patients. Journal of the American Dietetic Association. 93(9). A29–A29.
15.
Nikaein, Afzal, Lynn Morris, Charles M. Phillips, et al.. (1993). Characterization of T-cell clones generated from skin of patients with psoriasis. Journal of the American Academy of Dermatology. 28(4). 551–557. 12 indexed citations
16.
Jenkins, R N, Afzal Nikaein, Adriana Fontes Zimmermann, Katheryn Meek, & Peter E. Lipsky. (1993). T cell receptor V beta gene bias in rheumatoid arthritis.. Journal of Clinical Investigation. 92(6). 2688–2701. 93 indexed citations
17.
Nikaein, Afzal, Charles M. Phillips, Daniel A. Savino, et al.. (1991). Characterization of Skin-Infiltrating Lymphocytes in Patients with Psoriasis. Journal of Investigative Dermatology. 96(1). 3–9. 47 indexed citations
18.
Menter, Alan, et al.. (1990). Therapeutic and Immunologic Advances in Psoriasis. Baylor University Medical Center Proceedings. 3(2). 3–16. 1 indexed citations
19.
Nikaein, Afzal, et al.. (1989). Neopterin: a biochemical marker in the process of organ transplantation.. PubMed. 21(1 Pt 2). 2294–6. 3 indexed citations
20.
Gill, Joan Cox, et al.. (1985). Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell disease. The Journal of Pediatrics. 107(2). 251–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026